MedPath

Ascitic Fluid Microbiome in Liver Cirrhosis

Withdrawn
Conditions
Polymerase Chain Reaction
Microbiota
Ascitic Fluid, Microbiota
Sequence Analysis
Registration Number
NCT02813590
Lead Sponsor
Medical University of Graz
Brief Summary

Ascitic fluid microbiome is going to be investigated in this study by using internal transcripted spacer (ITS) and 16S ribosomal RNA (rRNA) polymerase chain reaction (PCR) and sequencing as conventional culture methods are lacking sensitivity regarding diagnosis of spontaneous bacterial peritonitis (SBP).

All patients with routinely performed ascitic fluid puncture and underlying liver cirrhosis are included in this study. Next generation sequencing (NGS) in ascitic fluid, skin swaps from puncture side and stool samples as well as conventional culture methods are performed to investigate the difference in the microbiome between patients with and without SBP.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Underlying decompensated liver cirrhosis
  • routinely performed ascitic fluid puncture
  • informed consent
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Next generation sequencing results from ascitic fluid samples1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of Graz

🇦🇹

Graz, Styria, Austria

Medical University of Graz
🇦🇹Graz, Styria, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.